SCHEMBL8720110

SCHEMBL8720110

CN(C)c1cccc2c(N(C)C)cccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.65
NEK2 P51955 1/20 0.65
LIMK1 P53667 1/20 0.65
DYRK1A Q13627 1/20 0.65
CLK4 Q9HAZ1 1/20 0.65
CA2 P00918 1/20 0.59
EP300 Q09472 1/20 0.56
KAT2B Q92831 1/20 0.56
KAT8 Q9H7Z6 1/20 0.56
GAA P10253 4/20 0.55
KDM4E B2RXH2 3/20 0.55
MAPT P10636 2/20 0.55
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
HTT P42858 1/20 0.52
HIF1A Q16665 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MCL1 Q07820 1/20 0.50
F2 P00734 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8990307 0.88 CHEK1 (0.73) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL29919884 0.88 CHEK1 (0.73) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL29862158 0.87 CYP1A2 (0.62) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL29922382 0.87 CHEK1 (0.79) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL31689542 0.87 CHEK1 (0.79) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL2886998 0.87 CHEK1 (0.79) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL469267 0.87 CYP1A2 (0.62) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL3582015 0.85 EP300 (0.73) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL11845814 0.85 CYP1A2 (0.59) CHEK1NEK2LIMK1DYRK1ACLK4
SCHEMBL29312925 0.85 CHEK1 (0.52) CHEK1NEK2LIMK1DYRK1ACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons SICPA HOLDING SA (CH) 2025-12-30 US disclosed
WO-2025078298-A1 METHODS FOR THE SAMPLING AND AUTHENTICATION OF MARKERS IN PRESSURIZED LIQUIFIED HYDROCARBON PRODUCTS SICPA HOLDING SA (CH) 2025-04-17 WO disclosed
EP-4069806-B1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2025-04-16 EP disclosed
EP-3951890-B1 N-TYPE SEMICONDUCTOR ELEMENT, METHOD FOR PRODUCING N-TYPE SEMICONDUCTOR ELEMENT, WIRELESS COMMUNICATION DEVICE AND PRODUCT TAG TORAY INDUSTRIES (JP) 2025-01-01 EP disclosed
US-20240327736-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2024-10-03 US disclosed
US-12031098-B2 Method of marking a petroleum hydrocarbon SICPA HOLDING SA (CH) 2024-07-09 US disclosed
US-12029107-B2 n-type semiconductor element, method for producing n-type semiconductor element, wireless communication device, and product tag TORAY INDUSTRIES, INC. (JP) 2024-07-02 US disclosed
EP-4069807-B1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-10-04 EP disclosed
US-20230103579-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-04-06 US disclosed
US-11584707-B2 Non-coordinating anion type activators containing cation having aryldiamine groups and uses thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-02-21 US disclosed
WO-2021110525-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2021-06-10 WO disclosed
US-20140197378-A1 DEUTERATED COMPOUNDS FOR LUMINESCENT APPLICATIONS E I DU PONT DE NEMOURS AND COMPANY (US) 2014-07-17 US disclosed
US-8409467-B2 Polishing liquid for semiconductor integrated circuit FUJIFILM CORPORATION (JP) 2013-04-02 US disclosed
US-8404146-B2 Polishing liquid and polishing method FUJIFILM CORPORATION (JP) 2013-03-26 US disclosed
US-20110147717-A1 DEUTERATED COMPOUNDS FOR LUMINESCENT APPLICATIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-23 US disclosed
US-5733903-A ANTITUMOR AGENTS WITH DIAMAGNETISM BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-03-31 US disclosed
EP-0512954-B1 Substituted naphthalenediamine stabilizers CIBA GEIGY AG (CH) 1995-03-08 EP disclosed
US-5198134-A Antioxidants for lubricants CIBA-GEIGY CORPORATION (US) 1993-03-30 US disclosed
EP-0512954-A1 Substituted naphthalenediamine stabilizers CIBA-GEIGY AG (CH) 1992-11-11 EP disclosed
US-4029637-A FIBERS AKZONA INCORPORATED (US) 1977-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110147717-A1 DEUTERATED COMPOUNDS FOR LUMINESCENT APPLICATIONS HDHD5, DDT, DLD CHEK1 2231/4885NEK2 583/4885LIMK1 518/4885
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons CYP4A11, CYP11B1, CYP11A1 CHEK1 3332/4885NEK2 3860/4885LIMK1 4029/4885
US-11584707-B2 Non-coordinating anion type activators containing cation having aryldiamine groups and uses thereof MYB, YAP1, AADAC CHEK1 2347/4885NEK2 204/4885LIMK1 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.